Related references
Note: Only part of the references are listed.Treatment of facial seborrheic dermatitis with pimecrolimus cream 1%: An open-label clinical study in Korean patients
Byung-Soo Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis
Erin M. Warshaw et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study
D. Seckin et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2007)
Pimecrolimus - an anti-inflammatory drug targeting the skin
M Grassberger et al.
EXPERIMENTAL DERMATOLOGY (2004)
Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial
D Rigopoulos et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Pimecrolimus: A review
AK Gupta et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2003)
Is topical metronidazole effective in seborrheic dermatitis?: A double-blind study
R Koca et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2003)
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis
T Luger et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Topical metronidazole in seborrheic dermatitis - A double-blind study
D Parsad et al.
DERMATOLOGY (2001)
Share Paper
